ZAID ALJAHMI: Open Payments
NPI 1679815112 · FARMINGTON HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 29 payments from 7 companies in 2025. Trend: 2023 $743 · 2024 $22 · 2025 $606
Food & beverage: $606
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $344 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $118 |
| Exact Sciences Corporation | 2 | $52 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| ABBVIE INC. | 1 | $25 |
| Lilly USA, LLC | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: CAPLYTA, Cologuard Collection Kit, TRELEGY ELLIPTA, VRAYLAR, JARDIANCE, XIFAXAN.
Industry payments across MI — which companies pay providers there.
